Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of the CG-100 Intraluminal Bypass Device in Colorectal and Coloanal Anastomoses: Prospective, Open Label, Randomized Trial

NCT04184973 is registered in ClinicalTrials.gov with Colospan Ltd. as lead sponsor.

NCT NCT04184973
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04184973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of the CG-100 Intraluminal Bypass Device in Colorectal and Coloanal Anastomoses: Prospective, Open Label, Randomized Trial
Lead sponsor
Colospan Ltd.
Phase
Not applicable
Overall status
Recruiting
Start date
June 23, 2020
Completion date
December 31, 2026
Enrollment
250 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer, rectal tumor, rectal/anal